John LaMattina

The thought that all drugs arise from government funded research is a fallacy.

The FDA had been previously reluctant to approve such a plan for safety concerns.

Entitled “Pharmaceutical innovation and the Inflation Reduction Act: What can we learn from the first half of 2023”, this policy brief examines whether “the IRA has ha...

Ultimately, these drugs will also lower the nation’s healthcare bill. They should be made available to all who need them. Insurance companies need to make this happen as soon as possible.

Medicare will save money but there will be fewer new medicines.

But keep in mind that it’s going to be a long while before such drugs are actually available.

At a time when the opportunities for discovering and developing new medicines is the greatest in our history, we will be doing less. What we really should be doing is investing more in order to generate new medicines thus reducing downstream healthcare costs.

So, why do people hate TV drug ads? Based on a survey conducted by STAT, the reasons vary.People also hate the descriptions of the side effects that drugs can cause.

The general population of men who had taken ED drugs had a 13% lower rate of MACE, 25% lower rate of mortality and 39% lower rate of CV mortality when compared to men who had not been exposed to ED drugs.

With the government no longer in the Covid-19 business, payment for these vaccines has now been passed on to insurers as happens with all vaccines.

Federal funding for providing Covid-19 vaccines to Americans will end this month and, as a result, most people will pay for their Covid-19 vaccines shots as they do their flu shots via their health insurance.

Fortunately, Shkreli’s behaviors have not been mimicked – until now.

Pfizer, which has produced the majority of Covid-19 vaccines with roughly seven billion doses to date, took no money from Operation Warp Speed (OWS) to discover, produce or distribute its vaccine.

When an article appears touting a reimagination of drug R&D that can cut costs from billions to millions, one has to take notice.

Nevertheless, the perception remains that extraordinary amounts of money are spent on TV ads at the expense of R&D. The data show that this isn’t the case.

But, if successful, this drug has the potential to indeed become the PCSK9 inhibitor for the masses. It could bring Merck full circle back to the days of Mevacor and Zocor.

Hatchett is absolutely correct when is says that the focus now needs to be on “the last mile” - providing these countries with the logistical and medical resources needed to actually get these vaccines into people’s arms.

He mainly focused on the fact that drugs cost more in the U.S. than in Europe and, as a result, Americans subsidize the costs of drugs for the rest of the world.

He is upset with Moderna’s behaviors post-approval of its Covid-19 vaccine, specifically its “ruthless corporate profit making.”

In non-hospitalized high-risk adults with COVID-19, Paxlovid was found to reduce the risk of hospitalization or death by 89% compared to placebo.